[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”2_3″ spacing=’yes’ last=’no’ background_color=” background_image=” background_repeat=’no-repeat’
background_position=’left top’ border_size=’0px’ border_color=” border_style=’solid’ padding=” class=” id=”]
News5050 – Market Reports
June 22, 2016
[/fusion_builder_column][fusion_builder_column type=”1_3″ spacing=’yes’ last=’yes’ background_color=” background_image=” background_repeat=’no-repeat’ background_position=’left top’ border_size=’0px’ border_color=” border_style=’solid’ padding=” class=” id=”][fusion_button link=’http://www.researchandexperts.com/Global/life-sciences/report/05IB-GMDHC08049CDB/’ color=’orange’ size=’large’ type=’flat’ shape=’pill’ target=’_blank’ title=’Fate Therapeutics, Inc. – Product Pipeline Review – 2016′ gradient_colors=’|’ gradient_hover_colors=’|’ accent_color=” accent_hover_color=” bevel_color=” border_width=’1px’ shadow=” icon=’fa-search’ icon_divider=’yes’ icon_position=’left’ modal=” animation_type=’0′ animation_direction=’down’ animation_speed=’0.1′ alignment=’left’ class=” id=”]View report[/fusion_button][/fusion_builder_column]
The report provides comprehensive information on the therapeutics under development by Fate Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
– The report provides overview of Fate Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Fate Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Fate Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
About Research and Experts:
Research and Experts brings you to the latest reports in market research on Life Sciences and much more.
Fia Rua, Deerpark
Bunratty, Co. Clare, Ireland
Check out Market Reports at www.researchandexperts.com